Korean J Pain.  2014 Jul;27(3):294-296. 10.3344/kjp.2014.27.3.294.

Antidepressant-induced Burning Mouth Syndrome: A Unique Case

• Raghavan S
• Puttaswamiah RN
• Birur PN
• Ramaswamy
• Sunny SP

• KMID: 2278243
• DOI: http://doi.org/10.3344/kjp.2014.27.3.294

Abstract

Burning Mouth Syndrome (BMS) is defined as a chronic orofacial pain syndrome, without evidence of mucosal lesions and other clinical signs of disease or laboratory abnormalities. Patients with BMS complain of burning pain in the mouth, xerostomia and taste disturbances. It is more common among women and the median age of occurrence is about 60 years. BMS may be primary or secondary to other diseases. The mainstay in the treatment of BMS includes antidepressants, benzodiazepines, and anticonvulsants. A few cases of BMS caused due to medication have been reported. The causative drugs include angiotensin-converting enzyme inhibitors, anticoagulants, antipsychotics, antiretrovirals, and benzodiazepines. This is a case report of a patient on antidepressants who developed symptoms of BMS thereby causing a dilemma in management.

Keyword

antidepressants; burning mouth syndrome; drug-induced BMS; fluoxetin; SSRI

MeSH Terms

Angiotensin-Converting Enzyme Inhibitors
Anticoagulants
Anticonvulsants
Antidepressive Agents
Antipsychotic Agents
Benzodiazepines
Burning Mouth Syndrome*
Burns
Facial Pain
Female
Fluoxetine
Humans
Mouth
Xerostomia
Angiotensin-Converting Enzyme Inhibitors
Anticoagulants
Anticonvulsants
Antidepressive Agents
Antipsychotic Agents
Benzodiazepines
Fluoxetine

Reference

1. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician. 2002; 65:615–620. PMID: 11871678.

2. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med. 2003; 14:275–291. PMID: 12907696.

3. Merskey H, Bogduk N. Task Force on Taxonomy of the International Association for the Study of Pain. Lesions of the ear, nose, and oral cavity. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle (WA): IASP Press;1994. p. 74–75.

4. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol. 1987; 63:30–36. PMID: 3468464.

5. Zakrzewska JM, Hamlyn PJ. Facial pain. In : Crombie IK, Croft PR, Linton SJ, LeResche L, Von Korff M, editors. Epidemiology of pain: a report of the Task Force on Epidemiology of the International Association for the Study of Pain. Seattle (WA): IASP Press;1999. p. 175–182.

6. Lamey PJ. Burning mouth syndrome: approach to successful management. Dent Update. 1998; 25:298–300. PMID: 10478025.

7. Lamey PJ, Lewis MA. Oral medicine in practice: burning mouth syndrome. Br Dent J. 1989; 167:197–200. PMID: 2789896.

8. Cibirka RM, Nelson SK, Lefebvre CA. Burning mouth syndrome: a review of etiologies. J Prosthet Dent. 1997; 78:93–97. PMID: 9237148.

9. Klasser GD, Fischer DJ, Epstein JB. Burning mouth syndrome: recognition, understanding, and management. Oral Maxillofac Surg Clin North Am. 2008; 20:255–271. vii. PMID: 18343329.

10. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103:S39.e1. S39.e13. PMID: 17379153.

11. Lauria G, Majorana A, Borgna M, Lombardi R, Penza P, Padovani A, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain. 2005; 115:332–337. PMID: 15911160.

12. Salort-Llorca C, Mínguez-Serra MP, Silvestre FJ. Druginduced burning mouth syndrome: a new etiological diagnosis. Med Oral Patol Oral Cir Bucal. 2008; 13:E167–E170. PMID: 18305436.

13. Levenson JL. Burning mouth syndrome as a side effect of SSRIs. J Clin Psychiatry. 2003; 64:336–337. PMID: 12716278.

14. Okeson JP. The various presentations of pain. Bell's orofacial pains: the clinical management of orofacial pain. 6th ed. Chicago (CA): Quintessence;2005. p. 107–128.

15. Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. Antidepressant drugs. Rang and Dale's pharmacology. 7th ed. Edinburgh: Elsevier/Churchill Livingstone;2012. p. 564–583.